Welcome to ISOP ISRAEL!

What we believe

Pharmacovigilance should not and will not remain only the expert’s job but must integrate all
stakeholders along the treatment pathway.

The future of Drug Safety lies in it becoming a truly multidisciplinary and integrated Public Health activity.​

We welcome those dedicated to improving drug safety.
ISOP ISRAEL provides the very platform to meet and discuss common problems and learn about innovative solutions to medication safety issues, to benefit from the experience of our exceptional International Advisory Board experts who are building the future of Drug Safety.

Who should be involved?

Healthcare professionals, from hospital and community, patients, Kupot holim, hospital managers and risk managers, Ministry of Health, industry, academy, IT and Artificial Intelligence companies,


Dr. Rina-Irene Fermont


Dear Colleagues,

I would like to welcome you to the International Society of Pharmacovigilance (ISOP).

I’m confident in your ability to develop and implement an efficient system of Risk Management. We have to promote and protect public health and the collaboration with Israel is indeed a wonderful added value.

As a former president of ISOP, you know that I have always supported the creation of the ISoP ISRAEL chapter and will continue to do so as President of CIOMS. I would like to thanks very much and to pay a tribute to my friend Rina-Irene. She is one of the pillars of the Society and I’m happy that she accepted to take the lead of the Israeli chapter.

I wish you fruitful meetings and projects.

Prof Hervé Le Louët

CEO ofWHO-UMC (Uppsala International Drug Monitoring Centre)

President of CIOMS,

Chair of the ISOP ISRAEL Advisory Board